DrugPatentWatch Database Preview

Msd Merck Co Company Profile

« Back to Dashboard

What is the competitive landscape for MSD MERCK CO, and when can generic versions of MSD MERCK CO drugs launch?

MSD MERCK CO has six approved drugs.

There are two US patents protecting MSD MERCK CO drugs.

There are ninety-three patent family members on MSD MERCK CO drugs in forty-five countries and seventeen supplementary protection certificates in seven countries.

Summary for Msd Merck Co

International Patents:	93
US Patents:	2
Tradenames:	5
Ingredients:	5
NDAs:	6

Drugs and US Patents for Msd Merck Co

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-005	Jul 10, 1998	AB	RX	Yes	Yes
Msd Merck Co	PIFELTRO	doravirine	TABLET;ORAL	210806-001	Aug 30, 2018		RX	Yes	Yes
Msd Merck Co	SINGULAIR	montelukast sodium	TABLET, CHEWABLE;ORAL	020830-002	Mar 3, 2000	AB	RX	Yes	No
Msd Merck Co	DELSTRIGO	doravirine; lamivudine; tenofovir disoproxil fumarate	TABLET;ORAL	210807-001	Aug 30, 2018		RX	Yes	Yes	8,486,975		Y	Y

Expired US Patents for Msd Merck Co

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-002	Dec 23, 1991	RE36481*PED
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-001	Dec 23, 1991	RE36520*PED
Msd Merck Co	SINGULAIR	montelukast sodium	TABLET, CHEWABLE;ORAL	020830-001	Feb 20, 1998	5,565,473*PED
Msd Merck Co	ZOCOR	simvastatin	TABLET;ORAL	019766-004	Dec 23, 1991	RE36481*PED

Paragraph IV (Patent) Challenges for MSD MERCK CO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Injection	115 mg/vial		2012-01-25
	for Oral Suspension	125 mg/Kit		2016-11-23
	Chewable Tablets	4 mg and 5 mg		2006-12-26
	Capsule	40 mg, 80 mg and 125 mg		2008-11-03
	Injection	150 mg/vial		2012-01-25
	Tablets	10 mg		2007-02-20

International Patents for Msd Merck Co Drugs

Country	Patent Number	Estimated Expiration
Serbia	50404
Mexico	2012011379
Spain	2609636
Hungary	230736

Supplementary Protection Certificates for Msd Merck Co Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0480717	9890027-7	Sweden		PRODUCT NAME: MONTELUKAST, R-(E)-1-1-3-2-(7-KLOR-2KINOLINYL)-ETENYL)-FENYL)-3-(2-(1-HYDROXI-1-METYLETYL)-FENYL)-PROPYL)-TIO)METYL)-CYKLOPROPANAETTIKSYRA, ELLER ETT FARMACEUTISKT GODDTAGBART SALT DAERAV, FOERETRAEDESVIS NATRIUMSALTET; NAT REG./DATE: 13944 19880111; FIRST REG.: FI EG 12766 19970825
0720599	SPC/GB05/010	United Kingdom		PRODUCT NAME: EZETIMIBE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN COMBINATION WITH SIMVASTATIN; REGISTERED: DE 58874.00.00 20040402; DE 58874.01.00 20040402; DE 58874.02.00 20040402; DE 58874.03.00 20040402; DE 58878.00.00 20040402; DE 58878.01.00 20040402; DE 58878.02.00 20040402; DE 58878.03.00 20040402; DE 58866.00.00 20040402; DE 58866.01.00 20040402; DE 58866.02.00 20040402; DE 58866.03.00 20040402; DE 58870.00.00 20040402; DE 58870.01.00 20040402; DE 58870.02.00 20040402; DE 58870.03.00 20040402; UK PL 19945/0003 20041118; UK PL 19945/0004 20041118; UK PL 19945/0005 20041118; UK PL 19945/0006 20041118; UK PL 19945/0007 20041118; UK PL 19945/0008 20041118; UK PL 19945/0009 200411
0480717	98C0022	France		PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825
0734381	SPC/GB04/011	United Kingdom		PRODUCT NAME: APREPITANT, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/03/262/001 20031113; UK EU/1/03/262/002 20031113; UK EU/1/03/262/003 20031113; UK EU/1/03/262/004 20031113; UK EU/1/03/262/005 20031113; UK EU/1/03/262/006 20031113

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Msd Intl
• Msd Intl Gmbh
• Msd Merck Co